Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

GPCR inhibitors

Structural insights into an intracellular biased agonist for GPCRs

Nature Structural & Molecular Biology volume 30, pages 1612–1614 (2023)Cite this article

Subjects

The targeting and modulation of G-protein-coupled receptors (GPCRs) has immense therapeutic potential. A study in Nature now reports on the successful targeting of intracellular allosteric sites that effectively bias GPCR signaling, which has opened new opportunities to develop safer therapeutic agents.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Structural details of PTH1R–ligand interactions.

References

  1. Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B. & Gloriam, D. E. Nat. Rev. Drug Discov. 16, 829–842 (2017).

    Article  CAS  PubMed Central  Google Scholar 

  2. Ortiz Zacarías, N. V., Lenselink, E. B., IJzerman, A. P., Handel, T. M. & Heitman, L. H. Trends Pharmacol. Sci. 39, 547–559 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Powers, A. S. et al. Nat. Chem. Biol. 19, 805–814 (2023).

    Article  CAS  PubMed Central  Google Scholar 

  4. Chan, H. C. S., Li, Y., Dahoun, T., Vogel, H. & Yuan, S. Trends Biochem. Sci. 44, 312–330 (2019).

    Article  CAS  Google Scholar 

  5. Katritch, V., Cherezov, V. & Stevens, R. C. Trends Pharmacol. Sci. 33, 17–27 (2012).

    Article  CAS  PubMed  Google Scholar 

  6. Kobayashi, K. et al. Nature 618, 1085–1093 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Baidya, M., Dwivedi, H. & Shukla, A. K. Nat. Struct. Mol. Biol. 24, 500–502 (2017).

    Article  CAS  PubMed  Google Scholar 

  8. Kumari, P., Inoue, A., Chapman, K., Lian, P. & Rosenbaum, D. M. Proc. Natl Acad. Sci. USA 120, e2219569120 (2023).

    Article  CAS  PubMed  Google Scholar 

  9. Mullard, A. Nat. Rev. Drug Discov. 22, 347–348 (2023).

    Article  CAS  PubMed  Google Scholar 

  10. Smith, J. S., Lefkowitz, R. J. & Rajagopal, S. Nat. Rev. Drug Discov. 17, 243–260 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The research program in M.B.’s laboratory is supported by the India Alliance DBT Wellcome Trust (IA/E/20/1/505691) and the Institute Seed Grant (SGT-100081) Indian Institute of Technology Jammu.

Author information

Authors and Affiliations

  1. Department of Biosciences and Bioengineering, Indian Institute of Technology Jammu, Jammu, India

    Neeraj Soni, Tarumoy Das & Mithu Baidya

Authors
  1. Neeraj Soni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tarumoy Das
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mithu Baidya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mithu Baidya.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soni, N., Das, T. & Baidya, M. Structural insights into an intracellular biased agonist for GPCRs. Nat Struct Mol Biol 30, 1612–1614 (2023). https://doi.org/10.1038/s41594-023-01100-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41594-023-01100-w

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research